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Summary
Background: Branched actin filament networks driving cell
motility, endocytosis, and intracellular transport are assem-
bled in seconds by the Arp2/3 complex and must be equally
rapidly debranched and turned over. One of the only factors
known to promote debranching of actin networks is the yeast
homolog of glia maturation factor (GMF), which is structurally
related to the actin filament-severing protein cofilin. However,
the identity of the molecular mechanism underlying debranch-
ing and whether this activity extends to mammalian GMF have
remained open questions.
Results:Using scanningmutagenesis and total internal reflec-
tion fluorescence microscopy, we show that GMF depends on
two separate surfaces for debranching. One is analogous to
the G-actin and F-actin binding site on cofilin, but we show
using fluorescence anisotropy and chemical crosslinking that
it instead interacts with actin-related proteins in the Arp2/3
complex. The other is analogous to a second F-actin binding
site on cofilin, which in GMF appears to contact the first actin
subunit in the daughter filament. We further show that GMF
binds to the Arp2/3 complex with low nanomolar affinity and
promotes the open conformation. Finally, we show that this
debranching activity and mechanism are conserved for
mammalian GMF.
Conclusions: GMF debranches filaments by a mechanism
related to cofilin-mediated severing, but in which GMF has
evolved to target molecular junctions between actin-related
proteins in the Arp2/3 complex and actin subunits in the
daughter filament of the branch. This activity and mechanism
are conserved in GMF homologs from evolutionarily distant
species.Introduction
The rapid assembly and disassembly of branched actin fila-
ment networks nucleated by the Arp2/3 complex is respon-
sible for driving the locomotion of a wide variety of cellular
structures [1]. The Arp2/3 complex is a seven-subunit assem-
bly consisting of two actin-like proteins and five unrelated pro-
teins [2, 3]. When bound to a nucleation-promoting factor
(NPF) of the Wiskott-Aldrich Syndrome protein (WASp) super-
family, it is capable of nucleating a new actin filament [4–6]4These authors contributed equally to this work
*Correspondence: goode@brandeis.edufrom the side of a preexistingmother filament [2]. Tomographic
reconstructions of these branches show that the Arp2/3 com-
plex is stably associated with junctions, positioned such that
the two actin-like subunits, Arp2 and Arp3, anchor the pointed
end of the daughter filament [7]. This mechanism of Arp2/3
complex nucleation has been known for some time; however,
much less is known about branched network pruning and
disassembly.
For continuous growth and force generation, branched actin
networks must be turned over as rapidly as they are polymer-
ized. The actin filament-severing protein cofilin/ADF (actin-
depolymerizing factor) plays one critical role in this process
[8–10]. Cofilin binds cooperatively to actin filament sides and
changes their twist by w5 [11–14]. Severing occurs at the
boundaries between cofilin-bound and unbound regions [15].
Cofilin also has been proposed to remove Arp2/3 complex
branch junctions [16, 17]. However, evidence suggests that
this effect occurs via cofilin targeting the mother filament
and not the Arp2/3 complex itself [17].
Cofilin is part of a larger superfamily of proteins called actin-
depolymerizing factor homology (ADFH) proteins, which also
includes twinfilin, Abp1/drebrin, coactosin, and glia matura-
tion factor (GMF) [18]. Although these other ADFH proteins
have all been implicated in regulating actin cytoskeleton
dynamics, their biochemical activities and genetic pheno-
types are not as well understood as those of cofilin. GMF fam-
ily proteins do not interact with actin but instead bind to the
Arp2/3 complex [19–21]. In reconstitution experiments, GMF
isoforms from yeast and mammals inhibit actin nucleation
stimulated by the Arp2/3 complex and the VCA domain of
WASp-family proteins [19, 21]. Remarkably, at much lower
concentrations, yeast Gmf1/Aim7 [22] removes daughter fila-
ments from their mothers without inducing severing events at
other locations [19]. Thus, Gmf1 may sever at branch junc-
tions. These observations have left many important questions
unanswered: Is GMF’s debranching mechanism related to
cofilin’s filament-severing mechanism? Is debranching a
conserved function? How does GMF interact with the Arp2/3
complex?
To address these questions, we performed scanning muta-
genesis of yeast Gmf1 to define surfaces important for its
in vivo and biochemical functions. This analysis revealed that
Arp2/3 complex binding and nucleation inhibition by GMF
depend specifically on a surface that is analogous to the sur-
face of cofilin that binds both actin monomer and filament,
which we term ‘‘site 1.’’ Debranching requires an additional
GMF surface that is analogous to a surface on cofilin that binds
specifically to F-actin, which we term ‘‘site 2’’ [23]. We
extended these analyses to mouse GMFg and determined
that debranching is a conserved function. Furthermore, we
found that a site 2 mutation in GMFg disrupts debranching
without affecting inhibition of nucleation activity, just as was
observed for this mutation in yeast Gmf1. A combination of
biophysical, modeling, and biochemical methods suggests
that GMF prunes daughter filaments by a cofilin-related
severing mechanism in which GMF uses site 1 to bind to
actin-related proteins (Arps) in the Arp2/3 complex and site 2
to bind the first actin subunit in the daughter filament.
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Figure 1. Site-Directed Mutagenesis of GMF1 and In Vivo Analysis
(A) Multiple sequence alignment of S. cerevisiae Gmf1/Aim7, S. cerevisiae
Cof1, S. pombeGmf1, andM.musculusGMFg. Allele numbers are indicated
(see also Table S1). GMF1 alleles that have defects in vivo are colored red;
GMF1 alleles that do not have in vivo defects are colored blue.
(B) Growth rates of GMF1 alleles. Optical density at 600 nm was monitored
continuously during growth in 96-well plates. Growth rates (see Supple-
mental Experimental Procedures for calculation) were averaged from three
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Site-Directed Mutagenesis of Gmf1
To dissect GMF function, we generated six gmf1 alleles based
on homology to cof1 alleles that have strong defects in cell
growth and actin binding. Subsequently, we generated an
additional 11 alleles that target clusters of charged or strongly
conserved residues in GMF. Thus, in total we mutated 38 res-
idues on Gmf1 within 17 different alleles (Figure 1A; see also
Table S1 available online).
In yeast, deletion of GMF1 exacerbates the growth defects
of a cof1-22 mutant, lowering the restrictive temperature
from 37C to 34C. Expressing Gmf1 under the GMF1 pro-
moter (from a low-copy plasmid) in the cof1-22 gmf1D strain
accelerates growth at 34C (Figure 1). By expressing our
Gmf1 mutants instead of wild-type, we identified six mutants
that grew significantly slower than a strain carrying wild-type
GMF1 (Figure 1B; Table S1). The mutated residues cluster in
three distinct regions of the protein (Figure 1C). The first
region, targeted by gmf1-17 (p = 0.03) and gmf1-20 (p <
0.01), corresponds to the same surface as site 1 of Cof1 [8]
(Figures 1D and S1). The second region, targeted by gmf1-
101 (p < 0.01) and gmf1-16 (p < 0.01), corresponds to the
same surface as site 2 (Figures 1D and S1). The third region,
targeted by gmf1-103, resides on a surface-exposed b strand
adjacent to gmf1-101 and is not part of either site.
Debranching Activities of Mutant Gmf1 Proteins
To better understand the activities that underlie GMF1 cellular
functions, we purified the mutant Gmf1 proteins that showed
defects in vivo. The mutant Gmf1-103 could not be purified;
thus, the growth defect may arise from a folding problem.
The folding stabilities of other Gmf1 mutant proteins were
similar to wild-type Gmf1, except for Gmf1-17 and Gmf1-16.
These had about 8C lower and 5C lower denaturation
midpoint temperatures (Tm), respectively (Figure S2). Note
that these Tm values are w20C higher than the growth tem-
perature, and thus the proteins are most likely stable in vivo.
We compared the debranching activity of these Gmf1 pro-
teins using real-time total internal reflection fluorescence
(TIRF) microscopy analysis of actin filament dynamics nucle-
ated by yeast Arp2/3 complex and WASp VCA [19]. In
reactions lacking Gmf1, branched filaments were rapidly
nucleated, and debranching events were rare (Figure 2A;
1.03 10246 0.53 1024 s21). We then performed this analysis
in the presence of 20 nM Gmf1 or a mutant variant (Figure 2B).
At this concentration, debranching is readily detectable and
subsaturating [19], making the assay sensitive to differences
in Ki. As shown previously [19], addition of wild-type Gmf1
accelerated the debranching rate by over 50-fold (Figures 2B
and 2C; 5.5 3 1023 6 0.5 3 1023 s21).
Both site 1 mutants of Gmf1 were found to be defective in
debranching to similar extents (Gmf1-17, 1.6 3 1023 6
0.2 3 1023 s21; Gmf1-20, 2.1 3 1023 6 0.4 3 1023 s21; Fig-
ure 2C; Table S2). Gmf1-101 was more strongly defective in
debranching (7 3 1024 6 2 3 1024 s21). Gmf1-16 (site 2) wasindependent experiments. Error bars represent SD.
(C) Cartoon model of mutants mapped onto the Gmfg structure (Protein
Data Bank ID 1VKK; unpublished JCSG/PSI structure http://dx.doi.org/10.
2210/pdb1vkk/pdb). Alleles that have defects in vivo are colored blue and
are indicated with text; alleles that are not defective in vivo are colored gold.
(D) For comparison, cartoon model of yeast Cof1 structure (PDB ID 1QPV;
[24]). Coloring is as in (C).
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Figure 2. Debranching Defects of Gmf1 Mutants
TIRF assay for actin filament debranching by Gmf1. See also Figure S2 and Table S2.
(A and B) Samples of branch lifetimemeasurements in the absence (A) or presence (B) of 20 nMwild-type Gmf1. Reactions contained the indicated proteins,
and frames were captured every 10 s. Branches are indicated with unfilled yellow arrowheads. Debranching events are marked by filled yellow arrowheads.
(C) Data as above were used to calculate debranching rates for each mutant Gmf1 protein (see Experimental Procedures). Error bars were estimated from
bootstrapping analysis (see Experimental Procedures).
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1039not significantly defective in debranching (3.9 3 1023 6
0.8 3 1023 s21).
In addition to the mutants above, we purified Gmf1-4, which
is a serine-to-glutamate substitution, as it targets a site
reported to be phosphorylated in mammalian GMF [20]. We
also purified Gmf1-105, because it targets a patch of acidic
residues proximal to Gmf1-103. Gmf1-4 debranched as effi-
ciently as wild-type Gmf1 (Figure 2C; Table S2; 5.0 3 1023 6
0.83 1023 s21), whereas Gmf1-105 debranched at a modestly
reduced rate (2.63 10236 0.53 1023 s21), demonstrating that
it is less impaired than any of the site 1 mutants. These results
show a correlation between mutant deficiencies in comple-
menting gmf1D in vivo and in debranching in vitro.
Inhibition of Nucleation by Arp2/3 Complex Depends
on Site 1 of Gmf1
At higher concentrations, Gmf1 also binds to Arp2/3 complex
in solution and inhibits Arp2/3 complex-mediated nucleation
[19–21]. Therefore, we tested the mutant Gmf1 proteins for
inhibition of nucleation by Arp2/3 complex. Wild-type Gmf1
robustly inhibited Arp2/3 complex-mediated nucleation (Fig-
ures 3A and 3B), whereas mutant Gmf1 proteins exhibited var-
iable defects (Figure 3B; Table S2). Gmf1-20 and Gmf1-17,
both of which target site 1, were defective in Arp2/3 complex
inhibition (note that Gmf1-17 and Gmf1-20 saturate at different
degrees of inhibition; see Discussion). In contrast, Gmf1-16
and Gmf1-101, both of which target site 2, were not signifi-
cantly impaired in Arp2/3 complex inhibition.
The results show that residues in site 1 are important for
inhibition of nucleation by Arp2/3 complex. In contrast, site 2
does not appear to be important for inhibition of nucleation
by Arp2/3 complex (Figure 3B), but it is critical for debranching
(Figure 2C). Thus, Gmf1-101 uncouples debranching from
Arp2/3 complex nucleation inhibition and suggests that
debranching requires additional molecular interactions (see
Discussion). Curiously, our two pseudo-wild-type mutants(Gmf1-4 and Gmf1-105) were strongly defective in nucleation
inhibition (Table S2). This suggests that nucleation inhibition
is not strongly correlated with in vivo defects and therefore
that debranching may be the more important activity in yeast
cells. Interestingly, Gmf1-16 showed no defects in nucleation
inhibition or debranching despite causing strong defects
in vivo (Figure 1), suggesting that this surface on Gmf1 may
contribute to regulation and/or localization in vivo. Indeed,
the analogous Cof1-16 site is implicated in PIP2 binding [25].
The mechanism of nucleation by Arp2/3 complex involves a
number of steps, including a conformational change that
brings the two Arp subunits into close proximity (known as
the ‘‘closed’’ conformation) [26]. We used negative-stain elec-
tron microscopy (EM) to directly image Gmf1-GFP-bound
Arp2/3 complex. Individual Arp2/3 complex particles were
picked and classified (Figure 3C). The class sums were used
to determine the fraction of Arp2/3 complexes in three confor-
mations (Figure 3D). Without Gmf1, 57.0% of Arp2/3 complex
particles were open, 13.7% intermediate, and 29.2% closed.
Upon addition of Gmf1-GFP, 70.2% of the particles were
open, 18.8% intermediate, and 11.0% closed (Figure 3D).
This is consistent with Gmf1 shifting the conformational distri-
bution of Arp2/3 complex away from the closed and toward the
open structure (chi-square test, p < 0.01).
Mouse GMFg Inhibits Nucleation by Arp2/3 Complex
and Promotes Debranching
Debranching activity has thus far been demonstrated only for
yeast Gmf1. We therefore performed debranching assays
using bovine Arp2/3 complex and purified Mus musculus
GMFg [20, 21]. This analysis revealed that GMFg indeed stim-
ulates debranching (Figure 4A), although it was less active than
yeast Gmf1. We then introduced an alanine substitution in
GMFg at three residues (R19A K20A K22A), corresponding to
the yeast Gmf1-101 (Figure 1A) allele that was defective specif-
ically in debranching. As observed for yeast Gmf1-101, mouse
A B
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Figure 3. Inhibition of Arp2/3 Complex-Mediated
Actin Nucleation by Wild-Type and Mutant Gmf1
Proteins
(A) Assembly assays containing 2 mM actin
(5% pyrene labeled), 20 nM Arp2/3 complex,
200 nM glutathione S-transferase (GST)-VCA
(from yeast Las17), and variable concentrations
of wild-type Gmf1. AU, arbitrary units.
(B) Degree of inhibition by wild-type and mutant
Gmf1 proteins at a range of concentrations.
Time to half-maximum (t1/2 max) fluorescent signal
was determined for each reaction and divided by
the t1/2 max for a reaction without Gmf1 performed
at the same time.
(C and D) Gmf1 shifts the distribution of Arp2/3
complexes toward the open conformation.
(C) Single-particle EM class-sum images of
Arp2/3 complex alone (top) and Arp2/3 com-
plex with Gmf1-GFP (bottom) in the open,
closed, and intermediate conformation. Class
averages for Arp2/3 complex with Gmf1-GFP
visibly bound are shown for the open and
intermediate conformations; closed was not
observed with Gmf1-GFP bound. Scale bar rep-
resents 10 nm.
(D) Analysis of relative frequencies of Arp2/3
complex conformations with and without Gmf1-
GFP. Particleswere counted regardless of whether Gmf1-GFP could be seen bound to Arp2/3 complex. Excluding those particles that could not be assigned
to a class, 3,758 particles were scored for Arp2/3 alone, and 5,584 were scored for Gmf1-GFP mixed with Arp2/3.
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ure 4A), demonstrating a mechanistic parallel between yeast
and mouse GMFs.
We further compared the abilities of wild-type GMFg and
mutant GMFg-101 to inhibit Arp2/3 complex-mediated nucle-
ation. GMFg and GMFg-101 inhibited actin assembly by
bovine Arp2/3 complex equally well (Figure 4B). Therefore,
mouse GMFg-101 exhibits properties similar to those of its
yeast counterpart: it is strongly impaired in debranching but
shows normal nucleation inhibition activity. Remarkably,
mouse GMFg could inhibit yeast Arp2/3 complex (Figure 4C),
providing further evidence that the nature of the interactions
between Arp2/3 complex and GMF is conserved across phylo-
genetic kingdoms.
Binding of Gmf1 to Arp2/3 Complex
Our finding that Gmf1 site 1 is critical for the debranching and
nucleation inhibition functions points to a possible interaction
between Gmf1 and one or both Arp subunits in the Arp2/3
complex (Arp2 and/or Arp3). Indeed, in cofilin, site 1 binds to
actin in a cleft between subdomains I and III [27], a region high-
ly conserved among actin, Arp2, and Arp3 [28].
To determine the stoichiometry of Gmf1-Arp2/3 complex
interactions, we performed multisignal sedimentation velocity
analytical ultracentrifugation [29]. Here, sedimentationwas fol-
lowed using Raleigh interference signals and absorbance at
492 nm. Gmf1 was tagged with GFP (referred to as Gmf1-GFP)
[19], providing a unique signal at 492 nm. From sedimentation
velocity data for these two signals (Figure S3), diffusion-
deconvoluted sedimentation coefficient distributions, c(s),
were constructed for yeast Arp2/3 complex and Gmf1-GFP
separately (Figure 5A). Free yeast Arp2/3 complex showed a
sedimentation coefficient of 9.4S (Table S3), similar to the
9.2S sedimentation coefficient reported for bovine Arp2/3
complex [30]. Free Gmf1-GFP sediments substantially more
slowly than Arp2/3 complex (Figure 5A), consistent with it
being present as a monomeric species. Similar experimentswere performed for mixtures of Gmf1-GFP and Arp2/3 com-
plex (Figures S3D and S3E), and multicomponent spectrally
and diffusion-deconvoluted sedimentation coefficient distri-
butions, ck(s), were fit for Arp2/3 complex and Gmf1-GFP
(Figure 5B). These distributions show that Arp2/3 complex
sediments more rapidly in the presence of Gmf1-GFP (Fig-
ure 5B; Table S3), and that a portion of Gmf1-GFP cosedi-
ments with Arp2/3 complex.
By optimizing the ratio of Gmf1-GFP that cosediments with
Arp2/3 complex in fitting (Figures S3F and S3G), we estimated
the stoichiometry of Gmf1-GFP association with Arp2/3
complex. This was performed for a range of Gmf1-GFP con-
centrations in the presence of approximately 700 nM Arp2/3
complex. The observed stoichiometries (Table S3; Figure S3J)
indicate two binding sites for Gmf1 on Arp2/3 complex. In
particular, a stoichiometry of two Gmf1-GFPs per Arp2/3 com-
plex is seen when 3.5 mM unbound Gmf1-GFP is present. Sub-
stoichiometric concentrations of Gmf1-GFP bound Arp2/3
complex completely, consistent with the first binding site
having a KD tighter than 30 nM (Figure S3H). At high Gmf1-
GFP concentrations, additional bound and free Gmf1-GFP is
observed (Figure 5B), consistent with a second, lower-affinity
binding site. Assuming two asymmetric binding sites for GMF
on Arp2/3 complex and using isotherms from effective particle
theory [31], the KD of the secondGmf1-GFP binding site is esti-
mated to bew2 mM (Figures S3I and S3J; Table S3).
Next, we measured the Arp2/3 complex binding affinities of
selected Gmf1 mutants using the fluorescence anisotropy of
Gmf1-GFP in the presence of yeast Arp2/3 complex. Gmf1-
GFP bound to Arp2/3 complex with a KD of 13 6 2 nM (Fig-
ure 5C). This is consistent with the high-affinity association
revealed by analytical ultracentrifugation.
We then compared the abilities of untagged wild-type and
mutant Gmf1 proteins to compete with Gmf1-GFP for binding
Arp2/3 complex by monitoring the decrease in anisotropy of
Gmf1-GFP. Competition with wild-type unlabeled Gmf1
demonstrated that it bound about as strongly as Gmf1-GFP,
A B C Figure 4. Mammalian GMFg Has Debranching
and Nucleation Inhibition Activities Similar to
Yeast Gmf1
(A) Debranching activities of mouse GMFg and
GMFg-101. Debranching analysis was performed
as in Figure 2, except that frames were captured
every 5 s, and reactions contained bovine Arp2/3
complex. Error bars were estimated from boot-
strapping analysis (see Experimental Proce-
dures).
(B) GMFg and GMFg-101 both inhibit nucleation
by bovine Arp2/3 complex and VCA. Reactions
contain 2 mM actin (5% pyrene labeled), 20 nM
bovine Arp2/3, 200 nM GST-VCA from human
WAVE1, and 2 mM mouse GMFg variants as indi-
cated.
(C) Mouse GMFg also inhibits nucleation stimu-
lated by yeast Arp2/3 complex with yeast
GST-VCA.
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3 nM) and Gmf1-101 (106 3 nM) were unaffected in their ability
to bind Arp2/3 complex (Figure 5D; Table S2), suggesting that
site 2 does not play a role in directly binding Arp2/3 complex.
Conversely, Gmf1-20 (210 6 50 nM) was strongly defective in
binding (Figure 5D; Table S2). However, Gmf1-17, also in
site 1 and defective in Arp2/3 inhibition, bound about as
strongly as wild-type (10 6 4 nM; Figure 5D; Table S2) (see
Discussion).
Gmf1 Interacts with Arp2, Arp3, and Arc40 Subunits
of Arp2/3 Complex
To identify Arp2/3 complex subunits (Arcs) directly contacting
or in close proximity to GMF, we chemically crosslinked Gmf1
to Arp2/3 complex. Crosslinking between Arp2/3 complex
subunits was prevented by decorating Gmf1 with N-hydroxy-
sulfosuccinimide (sulfo-NHS) before mixing with Arp2/3 com-
plex. A number of new bandswere observed that weremissing
from an unreacted sample of Arp2/3 complex alone, unmodi-
fied Gmf1 alone, decorated Gmf1 alone, and Arp2/3 complex
mixed with unmodified Gmf1 (Figure 6A). Blotting with aGmf1
antibodies revealed several new, high-molecular-weight
(MW) bands of discrete sizes, consistent with crosslinking to
the larger subunits of Arp2/3 complex (Figure 6B). Comparison
of silver-stained intensity of reacted and unreacted samples of
Arp2/3 complex showed that the unmodified Arp3 and ArpC1/
Arc40 bands have detectable decreases in intensity. Blotting
with aArp3 (Figure 6C), aArp2 (Figure 6D), and aArc40 (Fig-
ure 6E) showed that the new higher-MW bands contained
each of these proteins. In contrast, very little crosslinking
was apparent when blotting with aArc35 (Figure 6F). The
remaining Arp2/3 complex subunits did not show detectable
decreases in intensity and were not further explored. From
these data, we conclude that there are GMF binding sites on,
or proximal to, Arp2, Arp3, and Arc40. Intriguingly, these sub-
units are the same ones that bind VCA [30, 33–35], and
we observed that VCA can compete with GMF for binding
to Arp2/3 complex in a fluorescence anisotropy-based
assay (Figure S4). These results are also consistent with
competitive Arp2/3 complex binding observed between
Schizosaccharomyces pombe VCA and GMF [21].
Discussion
To address the mechanistic and structural basis for GMF’s
effects, we have performed a biochemical characterization,which leads to a model for its mechanism and interaction
with both free Arp2/3 complex and Arp2/3 complex in the
context of a filament branch junction. Although our study
focused on yeast Gmf1, we extended the key findings to
mammalian GMF homologs. This suggests that these Arp2/3
complex regulatory functions and mechanisms are widely
conserved. Below, we consider each of these conclusions.
GMF Site 1 Interacts with the Arp2/3 Complex and Mediates
Nucleation Inhibition
Our model for GMF interaction with the Arp2/3 complex is
highly informed by previous work on cofilin. The two actin
binding sites allow each cofilin molecule to bind two adjacent
subunits in an actin filament [12–14, 17, 36]. These interactions
lead to severing and creation of ends that accelerate disas-
sembly [10, 37]. Cofilin also uses site 1 to bind G-actin (at the
barbed end of the monomer) and inhibit nucleotide exchange
[27, 38, 39].
Two of our Gmf1 mutants (Gmf1-17 and Gmf1-20) were
designed to mimic mutations in site 1 that disrupted cofilin
binding to G-actin (Figures 1 and S1) [23]. Both of these
mutants disrupted the ability of Gmf1 to inhibit nucleation by
Arp2/3 complex in solution (Figure 3). Because Gmf1 binds
strongly to Arp2/3 complex (Figure 5; KD 10–13 nM) but lacks
detectable affinity for monomeric actin ([19]; S.B.P., unpub-
lished data), these results suggest that Gmf1 inhibits nucle-
ation by binding to the Arp subunits Arp2 and/or Arp3 in a
manner similar to how cofilin interacts with G-actin. Consistent
with this view, Gmf1-20 was defective in binding Arp2/3 com-
plex when measured by fluorescence anisotropy (Figure 5).
Gmf1-17was not impaired in binding to Arp2/3 complex (Table
S2), suggesting that this less-conserved part of the site 1 is not
essential for the interaction (Figure 5) or does not affect the
binding site reported on by the fluorescence anisotropy assay.
Surprisingly, Gmf1-17 and Gmf1-20 also appear to affect
nucleation inhibition in two different ways (Figure 3B),
Gmf1-17 by altering the Ki of the Arp2/3 complex-Gmf1 inter-
action, and Gmf1-20 by changing the activity level at satura-
tion. However, our crosslinking data show that Gmf1 interacts
with both Arp2 and Arp3 (Figure 6), and our analytical ultracen-
trifugation data reveal that there may be two Gmf1 binding
sites on the Arp2/3 complex (Figure 5). The specific defects
observed for Gmf1-20 and Gmf1-17 in nucleation inhibition
may therefore reflect altered interactions with two qualita-
tively distinct binding sites on the Arp2/3 complex, which
differentially contribute to nucleation inhibition. Although this
A B
C D
Figure 5. Binding of Wild-Type and Mutant Gmf1 Proteins to Arp2/3
Complex
(A and B) Binding interactions assessed by analytical ultracentrifugation.
(A) Sedimentation velocity analytical ultracentrifugation-derived c(s) distri-
butions for purified yeast Arp2/3 complex and Gmf1-GFP (data in Figures
S3A–S3C).
(B) Multisignal sedimentation velocity data were globally analyzed (data in
Figures S3D and S3E) to extract ck(s) distributions for Arp2/3 complex
(thin purple line) and Gmf1-GFP (thick green line). Observed sedimentation
information and binding stoichiometries are reported in Table S3, as are
related analyses at different concentrations (data not shown).
(C and D) Gmf1 binds to Arp2/3 complex with low nanomolar affinity.
(C) Fluorescence anisotropy of 4 nM Gmf1-GFP in the presence of varying
concentrations of yeast Arp2/3 complex. The fit reveals a KD of 13 6 2 nM.
(D) Fluorescence anisotropy of 4 nM Gmf1-GFP in the presence of 40 nM
Arp2/3 complex and various concentrations of unlabeled (nonfluorescent)
Gmf1. The determined KD values are shown in Table S2.
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to allow quantitative interpretation of these surprising results
at this time.A B
Figure 6. Gmf1 Interacts with Arp2, Arc40, and Arp3
Crosslinking analysis of sulfo-NHS-decoratedGmf1 and yeast Arp2/3 complex.
same components added are from the same crosslinking sample but separa
(A) or analyzed by western blotting with aGmf1 (B), aArp3 (C), aArp2 (D), aArpC1
are indicated in the anti-Gmf1 blot with ‘‘xg.’’ Gmf1-Arp2/3 crosslinking produc
[32]; one of these bands is indicated by ‘‘#.’’ Silver-stain band intensity that deDespite these uncertainties, a qualitative structural mecha-
nism for inhibition of nucleation by GMF can be inferred by
using known structures to impose the analogy of the cofilin
site 1 interaction with actin on the GMF interaction with Arp2
or Arp3. We constructed molecular models of this interaction
by docking the GMFg structure onto the structure of bovine
Arp2/3 structure [28], using the structure of the twinfilin-actin
complex [27] as a guide for positioning GMFg on the barbed
ends of Arp2 and/or Arp3 (Figure 7). We constructed several
versions of the model, including GMF bound to Arp3 or Arp2
in the inactive conformation of the Arp2/3 complex [28, 40].
WhenGMF is engagedwith Arp3 (Figure 7A), there are no addi-
tional contacts; when engaged with Arp2, GMF is also in con-
tact with ArpC1/Arc40 (Figure 7B). GMFmay bind to both sites
at higher concentrations, explaining why both interactions
were detected in our crosslinking experiments (Figure 6).
There are no major clashes in either of these models, with
the exception of a few residues in the Arp3 cleft, which could
presumably reposition upon GMF binding. Therefore, this
model is consistent with our scanning mutagenesis, crosslink-
ing, and analytical ultracentrifugation data.
How does GMF binding inhibit nucleation? Gmf1 appears to
bind to the same subunits in the Arp2/3 complex as VCA, and it
can be competed off of the Arp2/3 complex by the addition of
VCA (Figure S4). Thus, GMF may inhibit nucleation by inter-
fering with NPF effects on the Arp2/3 complex. Furthermore,
our EM data suggest that GMF alters the Arp2/3 complex
conformation, shifting the distribution of particles from the
closed to the open conformation (Figure 3). This is similar to
the proposed mechanism of Arp2/3 complex inhibition by
coronin [26].
GMF Site 2 Is Required Specifically for Debranching
If Gmf1 uses site 1 to interact with the barbed end of Arp2 or
Arp3, as we have modeled (Figure 7), then its site 2 would
interact with the first actin subunit of the daughter filament,
which forms a long-pitch dimer with one of the Arps. We
modeled the interaction of GMF site 2 with the first actinC D E F
Components weremixed as indicated at the top of each lane. Lanes with the
te gels. Samples were separated by SDS-PAGE and either silver stained
/Arc40 (E), or aArpC2/Arc35 (F) antibodies. Gmf1 self-crosslinking products
ts are indicated with ‘‘xl’’ and a bracket. A portion of Arc40 runs anomalously
creased in the crosslinked sample is indicated by ‘‘*.’’ See also Figure S4.
Figure 7. Model for Gmf1 Interactions with the
Arp2/3 Complex in Solution and at Actin Filament
Branch Junctions
(A and B) Proposed binding sites for GMF (white
ribbon) on free, inhibited Arp2/3 complex. Arp2/3
subunits are colored as follows: Arp2, red; Arp3,
orange; ArpC1, green; ArpC2, aqua; ArpC3,
magenta; ArpC4, dark blue; ArpC5, yellow. There
are two proposed sites, one interacting with Arp3
(A) and one interacting with Arp2 and ARPC1/
Arc40 (B). Details of the modeling are in Supple-
mental Experimental Procedures. In both
models, residues from the site 1 mutations
Gmf1-17 (light cyan spheres) and Gmf1-20 (light
pink spheres) contact Arp2/3 complex, but resi-
dues from the site 2 mutation Gmf1-101 project
away from the complex (light green spheres).
Arp2/3 complex subunit surfaces are rendered
using a 4 A˚ Gaussian blur.
(C) A model for GMF inhibition of actin nucleation
mediated by WASp VCA domain and Arp2/3
complex. Inhibition is hypothesized to occur
through competition between site 1 of GMF and
the C helix of VCA (represented by curvy white
line) for the same binding surface and through
alteration of Arp2/3 complex conformation.
(D and E)Modeling of the proposedGmf1 binding
sites in the context of the tomographic recon-
struction of Arp2/3 complex-actin filament
branch. Arp2/3 complex subunit surfaces are
rendered using an 8 A˚ Gaussian blur. Actin is
shown in gray surface.
(F) Amodel of GMF-induced debranching of actin
filaments in which contacts made by both site 1
and site 2 are required. GMF binding to the
Arp2/ArpC1 binding site is shown as the contact
site for simplicity. GMF engagement causes a
conformational change (white star), resulting in
disassembly of the branch (right side of arrow).
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cofilin-decorated actin filaments as a guide [13] (Figures
7D and 7E).
This model is supported by our scanning mutagenesis
results. Gmf1-101 lies in a surface that overlaps with the cofi-
lin mutant Cof1-6, which impairs F-actin but not G-actin bind-
ing [41]. This contact was also highlighted as being critical to
cofilin-F-actin interactions in a molecular dynamics simulation
[36]. Gmf1-101 was severely defective in debranching but had
a near wild-type ability to inhibit nucleation by Arp2/3 com-
plex (Figure 3) and showed normal binding to Arp2/3 complex
in solution (Figure 5). These observations support our struc-
tural model, which predicts that the surface perturbed
by Gmf1-101 is positioned away from Arp2/3 complex
(Figure 7) and in contact with the first daughter actin (Figures
7D and 7E).
In sum, our model proposes that GMF debranches fila-
ments through separate interactions with Arp3 and/or Arp2,
mediated by site 1, and through interactions with actin medi-
ated by site 2 (Figure 7F). The mechanism of debranching
therefore appears to be related to actin severing by cofilin.
Cofilin binding to filaments stabilizes a conformation in whichactin subdomain 2 is partially displaced
from the adjacent subunit, which may
lead to severing [13]. Similarly in our
model, GMF binding to the Arp2/3
complex at a branch junction requirespartial displacement of subdomain 2 of the daughter filament
actins from Arp2 and Arp3. Thus, GMF may stabilize a struc-
ture with weakened daughter filament-Arp2/3 complex inter-
actions, leading to dissociation of the daughter filament.
A final point to consider is that while GMF is a dedicated
debranching factor that does not sever filaments at other loca-
tions, ultimately its functions must be considered alongside
those of cofilin. Cofilin binds cooperatively to filament sides
and induces severing events at the boundaries of cofilin-deco-
rated and bare regions, leading to filament fragmentation
[10, 15, 37]. At higher saturation, this decoration also appears
to disrupt Arp2/3 complex binding, inducing debranching. In
the cellular context, it seems likely that both factors contribute
to debranching [16, 17]. An important future goal will be
to determine how GMF and cofilin influence each other and
function together to regulate actin filament debranching and
severing.Experimental Procedures
Detailed strain construction, protein purification, and analysis methods can
be found in the Supplemental Experimental Procedures.
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1044Growth Curves
pRS416-based plasmids carrying GMF1 alleles were transformed into
cof1-22 gmf1D. Strains were inoculated at low density in 200 ml of
synthetic media lacking uracil [42] in 96-well plates and grownwith agitation
in amultiwell plate reader (TecanGroup) at 34C. Calculation of growth rates
is described in the Supplemental Experimental Procedures.
TIRF Microscopy Debranching Assays
TIRF reactions were performed as described [43] and contained 1 mM rabbit
skeletal muscle actin (10% Oregon green labeled), 10 nM yeast or bovine
Arp2/3 complex, 100 nM dimeric VCA, and 20 nM wild-type or mutant
Gmf1 as indicated. Detailed methods can be found in the Supplemental
Experimental Procedures.
Actin Assembly Assays
Actin assembly assays using pyrene fluorescence were performed essen-
tially as described previously [43] using freshly gel-filtered rabbit skeletal
muscle actin and other proteins as indicated. In Figure 3, pyrene signal
was monitored in a multiwell plate reader (Tecan Group) set to excitation
wavelength 365 nm and emission wavelength 407 nm. Experiments in Fig-
ure 4 were monitored in a fluorescence spectrophotometer (Photon Tech-
nologies International). Time to achieve one-half of the change in pyrene
signal was determined by simple interpolation.
Fluorescence Anisotropy Measurements
A total of 4 nM of Gmf1-GFPwasmixedwith various concentrations of yeast
Arp2/3 complex in 50mMKCl, 10mM imidazole (pH 7.0), 1 mMMgCl2, 1 mM
EGTA, 0.5 mM DTT, and 0.1 mM ATP, incubated at room temperature for
15min prior tomeasuring the fluorescence anisotropy of GMF bymeasuring
polarized emission intensities at 510 nm when excited at 492 nm.
Analytical Ultracentrifugation
Analytical ultracentrifugation experiments were performed in an Optima
XL-I centrifuge equipped with an An50-Ti rotor (Beckman Coulter). Individ-
ual sample components were gel filtered into 5 mM HEPES (pH 7.0), 50 mM
KCl, 1 mM MgCl2, 1 mM EGTA, and appropriate volumes were combined
without concentration, diluting with additional buffer and one-tenth volume
of the same buffer supplemented with 1 mM ATP (final ATP concentration
was 100 mM). Roughly 400 ml of each sample was placed in charcoal-filled,
dual-sector Epon centerpieces and allowed to equilibrate at the experi-
mental temperature (20C) for several hours. Absorbance at 492 nm and
Rayleigh interference were monitored as the proteins sedimented at a rotor
speed of 42,000 rpm. ck(s) distributions were fit to the data using SEDPHAT
[29, 44, 45].
Electron Microscopy
Single-particle EM was performed essentially as described [46], with some
modifications. Full details can be found in the Supplemental Experimental
Procedures.
Chemical Crosslinking Analysis
Gmf1 was purified to the SOURCE15Q ion exchange step, and 1ml of 20 mM
Gmf1 was then sulfo-NHS labeled on carboxylic acids using a two-step pro-
tocol [47] and gel filtered into XLB (10 mM HEPES [pH 7], 1 mM MgCl2, and
50mMKCl). A total of 200 nMArp2/3 complexwas crosslinked to 2 mMGmf1
for 4 hr; the crosslinking reactions were quenched with 50 mM glycine
(pH 9.0). Samples were resolved by SDS-PAGE and imaged by silver stain-
ing or transferred to polyvinylidene fluoride and imaged by western blot.
Western blotting was performed using anti-Arp3 (y-152; Santa Cruz
Biotechnology), anti-Arp2 (yN-16; Santa Cruz Biotechnology), aArc40 [48],
aArc35 [49], or aGmf1 [19] primary antibodies.
Supplemental Information
Supplemental Information includes four figures, three tables, and Supple-
mental Experimental Procedures and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.04.058.
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